Document Detail


Sodium cromoglycate and eformoterol attenuate sensitivity and reactivity to inhaled mannitol in subjects with bronchiectasis.
MedLine Citation:
PMID:  21054671     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Background and objective:  Dry powder mannitol has the potential to be used to enhance clearance of mucus in subjects with bronchiectasis. A reduction in FEV(1) has been recorded in some subjects with bronchiectasis after inhaling mannitol. The aim of this study was to investigate if pre-medicating with either sodium cromoglycate (SCG) or eformoterol could inhibit this reduction in FEV(1) . Methods:  A double-blind, placebo-controlled, randomized cross-over study was conducted. Lung function and airway response to mannitol was assessed on a control day and then re-assessed after pre-medication with placebo, SCG and eformoterol in nine subjects. Sensitivity to mannitol, expressed as the dose required to induce a 15% fall in FEV(1) (PD(15) ), and reactivity to mannitol, expressed as the % fall in FEV(1) per mg of mannitol (response-dose ratio, RDR), are reported. Results:  Subjects had an FEV(1) of 68 ± 14% predicted, FVC of 97 ± 15% predicted and FEV(1) /FVC of 71 ± 8%. They were mildly hypoxemic and the SpO(2) was 95 ± 2%.They had a PD(15) to mannitol of 235 mg (95% CI: 150-368 mg) and a RDR of 0.057% fall in FEV(1) per mg (95% CI: 0.038-0.085). After pre-medication with SCG, PD(15) increased (773 mg, P < 0.05) and RDR was reduced (0.013, P < 0.05). Pre-medication with eformoterol also resulted in an increased PD(15) (1141 mg, P < 0.01) and a reduced RDR (0.009, P < 0.01). A small but significant decrease in SpO(2) from baseline was noted after mannitol in the presence of SCG (P < 0.05). Conclusions:  Pre-medication with either SCG or eformoterol protects patients with bronchiectasis from developing a significant reduction in FEV(1) after inhaling mannitol.
Authors:
Peter J Briffa; Sandra D Anderson; Deborah L Burton; Iven H Young
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Respirology (Carlton, Vic.)     Volume:  16     ISSN:  1440-1843     ISO Abbreviation:  Respirology     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-04-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9616368     Medline TA:  Respirology     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  161-6     Citation Subset:  IM    
Copyright Information:
© 2010 The Authors. Respirology © 2010 Asian Pacific Society of Respirology.
Affiliation:
Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown School of Biomedical Sciences, Charles Sturt University, Orange, New South Wales, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quantifying chronic cough: Objective versus subjective measurements.
Next Document:  Pulmonary rehabilitation improves exercise capacity and quality of life in underweight patients with...